IceCure Medical Ltd (ICCM) vs Revelation Biosciences, Inc. (REVB)
A side-by-side comparison of IceCure Medical Ltd and Revelation Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCM
IceCure Medical Ltd
$1.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
REVB
Revelation Biosciences, Inc.
$0.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ICCM vs REVB
growth of $100 · dividends reinvested · last 5yICCM -99.5% (-65.8%/yr)REVB -100.0% (-93.5%/yr)ICCM compounded faster over this window
Log scale — wide-divergence pair
ICCM REVB
ICCM vs REVB: by the numbers
- •REVB is the larger company ($3M vs $3M market cap).
- •Both run net losses; REVB's is the smaller (0.00% vs -427.67% net margin).
Metrics side by side
Valuation
| Metric | ICCM | REVB |
|---|---|---|
| P/S ratio | 0.72 | N/A |
| P/B ratio | 0.24 | 0.29 |
Profitability
| Metric | ICCM | REVB |
|---|---|---|
| Gross margin | 36.10% | 0.00% |
| Operating margin | -446.70% | 0.00% |
| Net margin | -427.67% | 0.00% |
| ROE | -141.90% | -106.79% |
| ROIC | -184.27% | -104.28% |
Growth (annualized)
| Metric | ICCM | REVB |
|---|---|---|
| Revenue CAGR (5Y) | -0.69% | N/A |
| Total return CAGR (5Y) | -63.05% | -93.52% |
Frequently asked
- How have ICCM and REVB total returns compared?
- Over the past 5 years, ICCM delivered -63.05% and REVB delivered -93.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.